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ABSTRACT
Illumina BeadArrays are among the most popular
and reliable platforms for gene expression profiling.
However, little external scrutiny has been given to
the design, selection and annotation of BeadArray
probes, which is a fundamental issue in data qual-
ity and interpretation. Here we present a pipeline
for the complete genomic and transcriptomic
re-annotation of Illumina probe sequences, also
applicable to other platforms, with its output avail-
able through a Web interface and incorporated into
Bioconductor packages. We have identified several
problems with the design of individual probes and
we show the benefits of probe re-annotation on
the analysis of BeadArray gene expression data
sets. We discuss the importance of aspects such
as probe coverage of individual transcripts, alterna-
tive messenger RNA splicing, single-nucleotide
polymorphisms, repeat sequences, RNA degrada-
tion biases and probes targeting genomic regions
with no known transcription. We conclude that
many of the Illumina probes have unreliable
original annotation and that our re-annotation
allows analyses to focus on the good quality
probes, which form the majority, and also to
expand the scope of biological information that
can be extracted.
INTRODUCTION
Illumina BeadArrays are microarrays consisting of
randomly positioned beads. A speciﬁc 50-mer oligonucleo-
tide sequence is assigned to each bead type, which is
replicated a random number of times on each array
( 40 times on average for the most common arrays).
The BeadArray technology can be used in a wide range
of applications, including gene expression studies, single-
nucleotide polymorphism (SNP) genotyping, methylation
proﬁling, and copy number variation analysis. Illumina
arrays have played an important role in large international
projects such as HapMap/GENEVAR (1), the Cancer
Genome Atlas (2) and large-scale transcriptional proﬁling
for the discovery of expression quantitative trait loci (3).
We, and others, have devoted attention to the improve-
ment of methods of preprocessing and statistical
analysis of Illumina microarray data (4–9), but probe
annotation is also a fundamental issue in data reliability.
No biologically meaningful interpretation can be
made without detailed knowledge of what transcriptomic
or genomic sequences the microarray probes map to,
and problems associated with probe identity can cause
misleading interpretation of data. Early expression
microarray platforms adopted a gene-centric approach
for probe design. This led to probes that fail to target
some biologically relevant isoforms, and cannot distin-
guish between those that are targeted. Even the current
platforms, with a few exceptions, provide limited informa-
tion in this regard. Furthermore, the relevance of exon and
exon junction levels of expression analysis has been
acknowledged in several studies (10–13).
Recent studies revealed that the high experimental
reproducibility between Aﬀymetrix GeneChips and
Illumina BeadArrays can be improved when the analysis
is restricted to probes on the two platforms that target
the same set of transcripts of a given gene (4,14). Several
eﬀorts in re-annotating Aﬀymetrix 25-mer probe
sequences have been shown to improve the reliability of
diﬀerential expression analysis studies (15–19), and the
importance of probe-level analysis of GeneChip data has
also been reported (20,21). The annotation of Illumina
probes poses a diﬀerent problem from Aﬀymetrix, as the
replicated observations for the same bead type all have
the same probe sequence attached. For an Aﬀymetrix
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multiple probes that can be used to interrogate the gene.
However, if an Illumina probe is defective, then all
measurements for that bead type are compromised,
which is a concern because many genes are represented
by only one bead type. Despite the incorporation of
annotation information in Bioconductor (22), published
re-annotation eﬀorts for BeadArrays have not gone
beyond the redeﬁnition of non-redundant and universal
oligonucleotide identiﬁers (23), the assignment of genes
and transcripts to probes on BioMart (24), the genomic
remapping of probes for visualization on the Ensembl
and UCSC genome browsers (25,26) or the alignment
of probes with RefSeq (27) and Ensembl transcripts for
platform comparison (28). In a previous study, we have
already discussed some of the implications of probe anno-
tation in the statistical analysis and summarization of
BeadArray data (5). We revealed, for the Mouse WG-6
version 1 platform, the existence of a large number of
probes mapping to intronic or intergenic regions, mainly
among those based on UniGene, which are likely to give
no meaningful signal. This was consistent with another
study reporting higher detectability of RefSeq transcripts,
when compared with non-RefSeq transcripts (3).
Here, we present a pipeline for the complete genomic
and transcriptomic re-annotation of Illumina probe
sequences, which can also be applied to other platforms.
Its output is publicly and interactively available online,
and incorporated in the current Bioconductor annotation
packages. We also compare the re-annotation with the
original from Illumina and evaluate its impact on the
interpretation of data from diﬀerent experiments.
METHODS
Annotation pipeline
The pipeline for re-annotation of microarray probes relies
on a Perl script and its key steps are illustrated in Figure 1.
Probe sequences provided by Illumina (http://www
.switchtoi.com/annotationﬁles.ilmn) are BLASTed (29)
(blastn, e-value=10
 6, DUST ﬁlter oﬀ—see
Supplementary Data for details) and BLATed (30)
(Web-based parameters) against the corresponding
genome (Human hg18—NCBI 36.1, Mouse mm9—
NCBI 37, Rat rn4—RGSC 3.4) and BLASTed against
all the transcripts in RefSeq (27), UCSC Known Genes
(31), UniGene/GenBank (32) and Ensembl (25). The
transcriptomic alignment reports are then parsed and the
selected transcripts are mapped to the genome and
annotated at the gene level, based primarily not only on
UCSC annotation tables (33) but also on UniGene (34)
and Ensembl (25). The genomic coordinates thereby
obtained are compared with the output of the genomic
BLAST and BLAT reports, to check for consistency and
to detect misalignments between the annotated transcripts
and the genome. A probe is considered to be speciﬁc if all
its transcriptomic matches align to one single genomic
location, irrespective of the number of gene isoforms
targeted and discrepancies between diﬀerent sources of
gene models. The described procedure also allows for
the identiﬁcation of probes mapping to intergenic or
intronic sequences.
Annotation of cytobands, sequence repeats, CpGs,
SNPs and overlapping micro RNAs (miRNAs) relies on
UCSC annotation tables (33). A quality grade is assigned
to each probe: ‘Perfect’ if the probe perfectly and uniquely
matches the target transcript; ‘Good’ if the probe,
although imperfectly matching the target transcript, is
still likely to provide considerably sensitive signal [up to
two mismatches are allowed, based on empirical evidence
that the signal intensity for 50-mer probes with <95%
identity to the respective targets is <50% of the signal
associated with perfect matches (35)]; ‘Bad’ if the probe
matches repeat sequences, intergenic or intronic regions,
or is unlikely to provide sensitive and speciﬁc signal for
any transcript (e.g. if the probe has three or more
mismatches with targets, or if it targets multiple
transcripts encoded from diﬀerent loci) and ‘No match’
if the probe does not (according to the criteria deﬁned
above) signiﬁcantly match any genomic region or tran-
script. We generally describe ‘Perfect’ and ‘Good’ probes
as being reliable, and probes in all other categories as
unreliable.
We have re-annotated probes from 8 BeadArray
platforms: HumanWG-6 versions 1, 2 and 3;
MouseWG-6 versions 1, 1.1 and 2; Rat Ref-12 version 1
and Human DASL. For Human and Mouse, Ref-8 probes
are a subset of the corresponding WG-6 probes. The
repertoire of probes for Human HT-12 is identical to
those for HumanWG-6 version 3.
ReMOAT, re-annotation tables and Bioconductor
ReMOAT (Re-annotation and Mapping for Oligonucleo-
tide Array Technologies) is a Web-based interface to the
re-annotation data generated by the described pipeline.
Data generated were processed using Perl and stored in
a relational database. ReMOAT uses an Apache Web
server, in a Linux environment, and a collection of PHP
and Perl CGI scripts provide the user interface coupled to
a MySQL RDBMS (http://www.mysql.com). The Web
interface provides access to a tool capable of converting
Illumina probe IDs, Entrez gene IDs or Ensembl gene IDs
to several other formats such as Illumina probe IDs,
Ensembl gene IDs, Entrez gene IDs, HGNC gene
symbols, Unigene IDs or Lumi IDs. The resulting Web
pages provide access to further information via links to
Wikigenes (36), iHOP (37), HGNC nomenclature (38),
Entrez Gene (39) and Ensembl (25) databases for each
gene. A second search page enables extraction of the
probe sequence, probe type, repeat masking results, GC
contents, associated CpG islands, miRNAs and SNPs and
quality assessment, generated by the pipeline for sub-
mitted Illumina IDs. Further search pages provide infor-
mation on probe location, transcript and non-speciﬁc
genomic hits (Supplementary Figure S1), and these are
documented online.
Full re-annotation tables and their detailed descrip-
tion, as well as a link to ReMOAT, can be
found online on http://www.compbio.group.cam.ac.uk/
Resources/Annotation/.
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re-annotated platform has been built using the
AnnotationDbi package. We chose reliable probes (i.e.
with ‘Good’ or ‘Perfect’ annotation) and retrieved
the RefSeq IDs as determined by our re-annotation.
These IDs were then used by AnnotationDbi to create a
database schema with predeﬁned mappings. The packages
can be installed by the same means as any other
Bioconductor package and are named according to the
platform annotated. For instance, the Human WG-6 V3
chip is available as the illuminaHumanv3.db (for data
summarized using Illumina’s BeadStudio software) or
illuminaHumanv3BeadID.db (for those starting from raw
Illumina data) packages.
Annotation tables and ReMOAT are updated at least
every 6 months, concomitantly with Bioconductor, and
consistent version labelling is used for tracking old
annotations.
Data sets
In order to evaluate the impact of probe annotation on the
analysis and interpretation of Illumina expression data,
we have looked at 27 Human WG-6 version 1 data sets
(926 arrays) derived from a wide variety of conditions
and tissue types (including breast, blood, artery, stem
cell, sperm). These were obtained from GEO (40) on 18
November 2008, searching for platform GPL2507 and
using the GEOquery Bioconductor package (41) to read
the data into R (42).
The MAQC project (43,44) selected two human RNA
samples for the comparison of diﬀerential expression on
microarray platforms. These were the Universal Human
Reference RNA (UHRR) from Stratagene (http://www
.stratagene.com/manuals/740000.pdf) (a pool of 10
cancer cell lines from multiple tissues) and Human
Brain Total RNA from Ambion (http://www.ambion
.com/catalog/CatNum.php?AM6050). The original
MAQC publication analyzed a dilution series of the two
samples hybridized at three diﬀerent locations. The
Illumina portion of the data was generated using the
Human WG-6 V1 platform and available in GEO
(GSE5350) and ArrayExpress (E-TABM-132). For this
study, we only consider the two extreme (pure) dilution
levels. The same samples have since been run on Human
WG-6 V2 BeadArrays by Asuragen Inc. and made
publicly available on Illumina’s Website (http://www
.switchtoi.com/datasets.ilmn). Finally, we have run
those same samples in-house on Human WG-6 V3
BeadArrays.
Another illustrative data set consisted of Human WG-6
V2 arrays from the study in (45), which compared gene
expression in hepatocytes between trisomic mice carrying
human chromosome 21 and their wild-type litter-mates.
To illustrate possible eﬀects of a SNP on the perfor-
mance of a probe, we have used the Japanese HapMap
(46) population. These 45 individuals have been examined
using Illumina expression BeadArrays, and addition-
ally genotyped, making them ideal for this purpose.
Expression information comes from the Human WG-6
V1 platform and was obtained from the GENEVAR (1)
project, and the corresponding genotypes were obtained
from BioMart (24).
Two Illumina training samples were run on the DASL
platform (47) using the standard cancer panel of 1506
probes. These consisted of RNA from the Illeum, and
corresponding DNA (run in duplicate and triplicate,
respectively).
Finally, we have looked at the preprocessed data from
Miranda and colleagues, GEO series GSE13733. Samples
consisted of MCF7 cells and were run on 10 Human WG-
6 V3 arrays. There were two diﬀerent drug treatments
(DZNep and 5-Aza-CdR), with four technical replicates
each, and two replicates of an untreated control sample.
Throughout the rest of the manuscript, these data
sets are referred to as GEO, MAQC (V1, V2 and V3),
Trisomy, HapMap, DASL and Miranda, respectively.
Figure 1. Annotation pipeline. Schematics of the computational pipeline ﬂow—see Methods section for details.
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All the analysis of Illumina microarray data was per-
formed in R (42). The analysis of the GEO data set is
described in more detail in (48). As the arrays in this
data set were generated from a diverse set of tissues and
processed using diﬀerent normalization methods, direct
comparisons between all arrays were not possible.
Therefore, the intensities on each array were ranked to
investigate the relative expression levels of the probes.
The average rank for each bead type across the entire
data set was then calculated and used to assess diﬀerences
between the diﬀerent annotation categories.
Two separate analyses were performed on the MAQC
data. First, a comparison of the MAQC samples run on
diﬀerent Illumina platforms was performed. Normalized
data generated from V1 and V2 platforms were taken
directly from the published summarized values and the
V3 data were BASHed (49) and summarized using
beadarray (50), and then median normalized. We were
then able to look at how particular probes of interest
evolved over diﬀerent versions of the annotation.
The MAQC data generated using Human WG-6 V1
BeadArrays were analyzed to look at the interaction
between ﬁltering, diﬀerential expression and the annota-
tion categories. Non-normalized MAQC V1 data were
read into R and a series of diﬀerent ﬁltering approaches
(Supplementary Data) were applied to all probes. A
diﬀerential expression analysis was also performed on
non-ﬁltered, quantile-normalized, data. The limma (51)
package was used to ﬁnd diﬀerentially expressed genes,
and the log-odds scores given by empirical Bayes moder-
ation of variances (52) were used to rank probes.
For the Trisomy study, the data were summarized,
quantile-normalized and log2-transformed using bead-
array (50). Diﬀerential expression was again quantiﬁed
by the log-odds after empirical Bayes moderation of
variances.
For DASL, data were analyzed and summarized using
default BeadStudio settings to provide a 5 1506 matrix
of observations.
RESULTS
Summary of annotation results
Table 1 summarizes the results of our re-annotation.
Illumina’s reported eﬀorts on improving the design and
annotation of human probes (http://www.illumina.com/)
have proven to be successful, as the percentage of
unreliable probes has substantially decreased: 44% for
WG-6 V1, 34% forV2and28% forV3. This improvement,
consistent with a previous report (28), is essentially due to
the increase in the proportion of RefSeq-derived probes
and in the reliability of the UniGene-derived ones
(Supplementary Figure S2). Illumina has indeed substan-
tially redeﬁned the RefSeq probes: only 16% of such
probes are conserved between versions 1 and 3, 3647
probes are completely novel in version 3 when compared
to version 2 and 5720 probes were redesigned (i.e. same
target, diﬀerent location) in the updating. Of the probes
chosen for the human DASL platform, 95.6% are
reliable (a much higher percentage than for the other
platforms). This is not surprising, as there are fewer
probes for DASL and they target known and well-
curated cancer-related genes.
The outstanding wealth of mouse transcriptomic
sequences and respective annotation in the databases
reﬂects on the quality of the probes for mouse, superior
to human’s. Interestingly, the increase in reliability from
version to version has been very subtle (84% reliable
probes for V1, 85% for V1.1, 86% for V2).
Table 1. Results of re-annotation of Illumina probe sequences
Platform Source Total number
of probes
Perfect Good Bad No match Intronic Intergenic Splice
junctions
Repeat
sequences
Human WG-6 v3 RefSeq 36079 73.5% 28154 78.0% 909 2.5% 6737 18.7% 279 0.8% 749 2.1% 1306 3.6% 2791 7.7% 4254 11.8%
UniGene 12997 26.5% 6389 49.2% 88 0.7% 5801 44.6% 719 5.5% 37 0.3% 160 1.2% 58 0.4% 3987 30.7%
Total 49076 34543 70.4% 997 2.0% 12538 25.5% 998 2.0% 786 1.6% 1466 3.0% 2849 5.8% 8241 16.8%
Human WG-6 v2 RefSeq 30808 63.3% 23755 77.1% 747 2.4% 6028 19.6% 278 0.9% 747 2.4% 1320 4.3% 2246 7.3% 3580 11.6%
UniGene 17894 36.7% 7698 43.0% 117 0.7% 8435 47.1% 1644 9.2% 284 1.6% 1211 6.8% 57 0.3% 5598 31.3%
Total 48702 31453 64.6% 864 1.8% 14463 29.7% 1922 3.9% 1031 2.1% 2531 5.2% 2303 4.7% 9178 18.8%
Human WG-6 v1 RefSeq 26098 55.2% 20769 79.6% 783 3.0% 4421 16.9% 125 0.5% 238 0.9% 871 3.3% 1681 6.4% 2921 11.2%
UniGene 21198 44.8% 4949 23.3% 130 0.6% 15847 74.8% 272 1.3% 4113 19.4% 9405 44.4% 106 0.5% 3463 16.3%
Total 47296 25718 54.4% 913 1.9% 20268 42.9% 397 0.8% 4351 9.2% 10276 21.7% 1787 3.8% 6384 13.5%
Human DASL Total 1506 1402 93.1% 37 2.5% 66 4.4% 1 0.1% 0 0.0% 2 0.1% 17 1.1% 40 2.7%
Mouse WG-6 v2 RefSeq 23031 50.9% 19115 83.0% 556 2.4% 3150 13.7% 210 0.9% 383 1.7% 926 4.0% 1080 4.7% 1567 6.8%
MEEBO 16591 36.6% 15267 92.0% 318 1.9% 863 5.2% 143 0.9% 47 0.3% 6 0.04% 384 2.3% 692 4.2%
Riken 5659 12.5% 3574 63.2% 292 5.2% 1749 30.9% 44 0.8% 0 0.0% 0 0.0% 292 5.2% 1636 28.9%
Total 45281 37956 83.8% 1166 2.6% 5762 12.7% 397 0.9% 430 0.9% 932 2.1% 1756 3.9% 3895 8.6%
Mouse WG-6 v1.1 RefSeq 32342 69.3% 28560 88.3% 394 1.2% 3140 9.7% 248 0.8% 431 1.3% 961 3.0% 1026 3.2% 1556 4.8%
MEEBO 9512 20.4% 7306 76.8% 290 3.0% 1322 13.9% 594 6.2% 191 2.0% 19 0.2% 113 1.2% 953 10.0%
Riken 4784 10.3% 2832 59.2% 261 5.5% 1644 34.4% 47 1.0% 0 0.0% 0 0.0% 171 3.6% 1542 32.2%
Total 46638 38698 83.0% 945 2.0% 6106 13.1% 889 1.9% 622 1.3% 980 2.1% 1310 2.8% 4051 8.7%
Mouse WG-6 v1 RefSeq+
MEEBO
34159 85.5% 29196 85.4% 530 1.6% 4080 11.9% 353 1.0% 582 1.7% 967 2.8% 866 2.5% 2211 6.5%
Riken 5809 14.5% 3665 63.1% 294 5.1% 1800 31.0% 50 0.9% 0 0.0% 0 0.0% 302 5.2% 1694 29.1%
Total 39968 32861 82.2% 824 2.1% 5880 14.7% 403 1.0% 582 1.5% 967 2.4% 1168 2.9% 3905 9.8%
Rat RefSeq v1 RefSeq 22523 15534 69.0% 322 1.4% 6189 27.5% 478 2.1% 295 1.3% 2533 11.2% 933 4.1% 1187 5.3%
The number of probes in each annotation category is indicated; percentages (italics) indicate the corresponding proportion for the associated source.
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is 70%, lower than that observed for RefSeq human
(81%) and mouse (85%) probes. This can be explained
by the relative scarcity of transcriptomic information
available for rat, when compared with the other two
species.
Our transcriptomic annotation of probes is very similar
to that of Du et al. (23) for all platforms and to Ensembl’s
(25) for Human versions 1 and 2. However, they fail to
take into account probes matching the reverse strand of
the target transcript, which is the cause of most of the
 2% discrepancy. Our pipeline rejects such probes, as
probes are supposed to be strand speciﬁc. The strand
speciﬁcity is of particular importance given the large
number of human antisense transcripts (53,54).
Filtering and diﬀerential expression analysis
Figure 2A shows how, for the GEO data set, the average
expression ranks of genes vary between diﬀerent
Figure 2. Impact of annotation on expression analysis. (A) Box plots of the average expression ranks of probes, calculated across the GEO arrays,
for each annotation category (box widths proportional to the number of probes in the respective category); (B) proportions of probes retained by
each ﬁltering method applied to the MAQC V1 data set (y-axis) as a function of the chosen cut-oﬀ (x-axis); (C) proportions of probes of each
category (y-axis) found in a gene list of certain length arising from a diﬀerential expression analysis of the MAQC V1 data (x-axis). For panels (B)
and (C), the colour code is the same as used in (A); dashed lines are associated with quality grade categories and solid lines with coding zones.
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probes annotated as reliable are observed to have a high
mean rank ( 27000 for ‘Perfect’ and ‘Good’), whereas
other probes (e.g. matching to an intronic or intergenic
region, or with no matches) have a much lower mean
rank of below 20000. The ﬁgure also shows a decreased
mean rank of probes mapping closer to the 50 end of
transcripts, consistent with the instability of RNA
molecules and their degradation typically starting from
the 50 end. This eﬀect has been addressed in the probe-
level models for the analysis of Aﬀymetrix (20) and
motivates most of the manufacturers, including Illumina,
to design their gene expression platforms with probes tar-
geting the 30 end of transcripts.
Among the 100 bead types with the highest average
rank (>46891), 39 are found to target ribosomal
proteins that function in protein biosynthesis and some
of which have been previously found to be housekeeping
or reference genes (55,56). Thus, these genes are often
considered useful for normalization. Indeed, 4 genes
from this list are also found in the table of top 15 candi-
date housekeeping genes presented in (55), which includes
13 ribosomal proteins. Other interesting features of these
100 probes are that 53 have multiple matches to the
genome, 24 map to repeat regions and 41 map to SNPs
(Supplementary Table S1).
For the MAQC V1 data set, Figure 2B shows that, for
ﬁltering based both on expression level (‘Detection’ and
‘Expression’) and variability (‘IQR’), probes annotated as
‘Perfect’ or ‘Good’ are more readily retained than those
classiﬁed as ‘Bad’ or not matching.
Figure 2C shows, in terms of our annotation categories,
the composition of the ranked gene lists from the diﬀer-
ential expression analysis of the MAQC V1 data. As
expected, bead types annotated as reliable occur towards
the top of the list. On the other hand, genes mapping to
intronic and intergenic regions, or having no match at all,
are ranked lower in the list.
SNPs and mismatches
Having presented the general good performance of
Illumina probe design, we now discuss some speciﬁc cases
where the performance requires careful interpretation.
The retention, by the ﬁltering methods, of probes with
mismatches (named ‘Good’) and their generally high
expression ranks suggest that hybridization is still
possible when probe and target sequences do not match
perfectly. Furthermore, for Human V2 over 100 of the
detected mismatches can be explained by SNPs and 5791
probes map to annotated SNPs. Therefore, allelic ambi-
guity needs to be taken into account when interpreting
gene expression data. Figure 3 and Supplementary
Figure S3 illustrate an association between genotype and
measured expression in the Japanese HapMap population
that is consistent with a mismatch inducing a signiﬁcant
decrease in registered intensity. Similar eﬀects have been
previously reported for Aﬀymetrix (57).
As another example, human probes ILMN_1692545
and ILMN_1670800 (WG versions 2 and 3) diﬀer in
only one nucleotide (C/A at position 19) that corresponds
to SNP rs13082444 (G/T for the genomic Watson strand).
A striking diﬀerence in expression between the two
Figure 2. Continued.
e17 Nucleic Acids Research, 2010,Vol. 38,No. 3 PAGE 6 OF 13Figure 3. Association between genotype and measured expression. (A) The sequence we examine is in the BCKDHB gene on chromosome 6, which
contains a SNP (rs7740958—T/C) at position 7. The Illumina probe targeting this sequence (GI_34101271-I) contains a C at this location. There is
also a probe (GI_34101266-A) targeting a constitutive splice junction of BCKDHB and matching no known SNPs. [Figure built based on UCSC
Genome Browser graphics (26).] (B) Box plots of the log2 expression ratios in the Japanese HapMap population according to the rs7740958
genotype.
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(median of 48 fold). According to the current human
genome annotation, these probes primarily target an
intergenic region and, therefore, no known transcript.
However, these probes were designed to target transcripts
XM_933970.1 and XM_944901.1 that perfectly map to the
two genomic variants and have since been removed from
the databases (Supplementary Figure S4).
We have listed, for the three Human WG-6 platforms,
all the pairs of probes diﬀering in 1, 2 and 3 nucleotides
(Supplementary Table S2). There is a substantial increase
in the number of probe pairs diﬀering in one nucleotide
from V1 (9) to V2 (177), suggesting that attention to SNPs
and allele speciﬁc expression has been given in Illumina’s
redesigning of probes.
Repeat sequences
It is not expected that intergenic and intronic regions of
the genome will feature in gene expression studies.
However, there are a few examples of probes that fall
into these categories yet are highly ranked on all GEO
arrays (outliers in categories ‘Bad’ and ‘Intergenic’ in
Figure 2A). Most of such probes include repeat sequences
and are partially or totally ‘masked’ by RepeatMasker
(http://www.repeatmasker.org). They are likely to cross-
hybridize and provide non-speciﬁc signal. We have, there-
fore, classiﬁed all ‘masked’ probes as ‘Bad’. A good
example of how these probes can impact on the analysis
of gene expression is provided by the study in (45), where
our annotation has been used. As illustrated in Figure 4,
all human transcripts but one overexpressed in Tc1 mouse
livers (whose cells contain one human chromosome 21,
apart from the normal mouse karyotype), when
compared to their wild-type litter-mates, are either from
chromosome 21 (as expected) or targeted by probes con-
taining repeat sequences. Moreover, the number of
overexpressed ‘masked’ transcripts is statistically signiﬁ-
cant. These results suggest that repetitive probes,
although not originally annotated as mapping to chromo-
some 21, are non-speciﬁcally binding to repeti-
tive transcripts from that chromosome. Assuming
transcripts from human chromosome 21 are those truly
diﬀerentially expressed between Tc1 and normal litter-
mates, ignoring the information about repeat sequences
would have led us to a false discovery rate of 37%,
instead of the current 2%.
Another interesting example is provided by a set of six
genomically clustered human probes, two of which were
designed to target the PSMC1 gene while the other four
match spurious transcripts that have since been removed
from the databases. The six probes exhibit a good match
not only with the PSMC1 locus but also with several other
regions in diﬀerent chromosomes (including an intronic
sequence of the PLCZ1 locus) and the relative position
of the matches is generally conserved (Supplementary
Figure S5).
An even more striking example of potential non-
speciﬁcity of hybridization is given by a set of 15 probes,
each targeting transcripts from multiple genes from
the GAGE cluster on chromosome X (Supplementary
Figure S6).
Alternative splicing
Although for Illumina the majority of genes are targeted
by one unique reliable probe type, there are still a few
thousand genes covered by more than one probe type
(Supplementary Figure S7). Almost all multi-exon genes
undergo alternative splicing (58,59) and, therefore,
comprise multiple isoforms. Probes targeting diﬀerent
transcripts for the same gene can generate ambiguity in
the deﬁnition of gene expression but they also provide an
opportunity for the detection of alternative splicing. This
is well illustrated in Figure 5 and Supplementary Figure S8
for the human CAST (calpastatin) gene, covered by at
least six diﬀerent probe types for any of the platforms.
The probes target the constitutive last exon, several alter-
native ﬁrst exons and alternative splice junctions. The
diﬀerences between probes, not only in expression levels
but also in diﬀerential expression ratios, show the extra
insight brought by a transcript/exon-centric analysis and
how misinformative a gene-centric summary of data can
be. This example is also an illustration of the importance
of strand speciﬁcity of probes, as ILMN_1752145 targets
the 30-most exon of an antisense ERAP1 (endoplasmic
reticulum aminopeptidase 1) transcript and genomically
overlaps with a constitutive exon of CAST.
Figure 4. Eﬀect of repetitive sequences on gene expression
measurements. Volcano plot (y-axis: empirical Bayes log-odds of diﬀer-
ential expression; x-axis: log2 fold change in expression) comparing the
expression of human transcripts in livers between Tc1 mice carrying a
human chromosome 21 and their wild-type litter-mates (Tc0). Blue dots
depict probes targeting genes on human chromosome 21 and red dots
probes comprising human RepeatMasker sequences. The dashed line is
an arbitrary cut-oﬀ for diﬀerential expression based on the assumption
that there are no human sequences transcribed in the wild-type mouse
and, therefore, no human transcript should be overexpressed in Tc0.
The P-values (Fisher’s exact test) show that the numbers of
diﬀerentially expressed transcripts from human chromosome 21 (blue)
and comprising human repeats (red) are both highly signiﬁcant.
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We clearly show, for the DASL platform, the increase
in relative signal intensity for such probes from hybridiza-
tion against genomic DNA to hybridization against
transcriptomic RNA (Supplementary Figure S9).
The interpretation of expression data can also be
aﬀected by ambiguity in the deﬁnition of a gene or, in
other words, by distinct genes sharing the same locus.
For example, two diﬀerent human genes, CPNE1
(copine I) and RBM12 (RNA-binding motif protein 12),
share their most 50 exons (as well as the promoter region)
(60). Three Illumina probes (ILMN_1701229, ILMN_
2276000, ILMN_2276002) target both an alternative
non-coding ﬁrst exon of CPNE1 and the last and only
coding exon of RBM12 (Supplementary Figure S10). An
even more striking example is the PCDHG locus on
human chromosome 5, which seems to cluster several
distinct genes and diﬀerent isoforms of the same gene
(generally characterized by alternative ﬁrst exons)
(Supplementary Figure S11). Illumina designed probes
to target virtually all the diﬀerent transcripts and
annotates each of them as a distinct gene. In contrast,
UniGene (34) considers them to be all part of the
PCDHGC3 gene cluster. This illustrates well the diﬃculty
in choosing a suitable universal gene identiﬁer and that
even a system like UniGene, speciﬁcally designed for
organizing transcripts into non-redundant gene-oriented
clusters and, particularly, popular in meta-analyses (61),
cannot deal with all the idiosyncrasies associated with
deﬁning what a gene is.
Another example of the particular importance of
analyzing expression at the transcript level for genes con-
taining alternative promoters and ﬁrst exons is given by
the CDKN2A (cyclin-dependent kinase inhibitor 2A) locus
for both human and mouse. The gene has two alternative
ﬁrst exons, separated by over 10 Kb, that give rise to two
structurally and functionally distinct isoforms: p16INK4a
Figure 5. Importance of alternative splicing on the interpretation of gene expression data. Schematics of the structure of the human CAST gene,
with exons depicted by numbered boxes in light blue and all annotated alternative splicing events represented by the associated thin black dashed
lines. The three upper tracks represent the logged expression levels for all the probes targeting the CAST locus for each of the three human Illumina
WG platforms. Bars are positioned according to the relative position of the respective probes in the locus. Bar height is proportional to the average
log gene expression in the MAQC data: red for brain samples and blue for reference samples. The coloured dashed lines indicate the respective
average expression levels of probes targeting CAST for each sample type. The short coloured full lines in the middle of the V2 track indicate the
expression level of CAST estimated by the original Illumina gene summarization procedure for each sample type; black stars identify V2 probes
targeting CAST according to the original Illumina annotation. Black arrows identify probes mapping to the reverse strand. The three lower tracks
represent the corresponding log-ratios. This ﬁgure shows that a gene-centric analysis indicating underexpression of the CAST gene in brain (dashed
blue line) might be biased by a brain-speciﬁc skipping of exon 30 and/or an alternative ﬁrst exon.
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reading frame, involved in the stabilization of p53 by
sequestering of MDM2). All the Human and Mouse
WG-6 platforms have three probes targeting CDKN2A:
one for each of the alternative ﬁrst exons and one for
the common last exon (Supplementary Figure S12).
Annotating the trio of probes as having the same gene
target would, for most experiments, lead to the observa-
tion of inconsistency between the associated three gene
expression measurements.
Any signal given by probes matching an intron or exon
junction and, therefore, partially intronic, like human
ILMN_1690644 (Supplementary Figure S13), is very dif-
ﬁcult to interpret. In particular, this holds when there is no
evidence for splice variants involving an alternative splice
site or a retained intron.
Generally, probes targeting constitutively transcribed
sequences are expected to exhibit stronger signal than
probes matching only alternative transcripts. The former
are, therefore, more suitable for a gene-centric analysis of
data. We support this assumption by showing that there is
a positive correlation between the proportion of isoforms
in a gene targeted by a probe and its intensity
(Supplementary Figure S14).
Other interpretation issues
There are examples of other aspects of the design of
Illumina probes that might aﬀect the interpretation of
expression data.
Human WG-6 V3 probes ILMN_2311089 and
ILMN_1738027 both perfectly target a constitutive exon
of BRCA1 (breast cancer 1) and overlap in 49 out of their
50 nucleotides (Supplementary Figure S15A). However,
for all samples in the Miranda data set (GEO series
GSE13733), ILMN_1738027 exhibits higher intensities
(Supplementary Figure S15B). Hybridization dynamics
are particularly sensitive to poly-C/poly-G tracts at the
end of the probes, and it is plausible that the one-
nucleotide increase in length of the poly-C tract, in this
case, would account for the observed discrepancy.
Probes ILMN_1726308 and ILMN_1756139 were
designed to have distinct gene targets yet diﬀer in only
one nucleotide. The ﬁrst perfectly and uniquely targets
the 30UTR of the mono-exonic FAM10A4 transcript on
chromosome 13. The second perfectly targets the pre-
dicted transcript XR_038903.1 on chromosome X. Some
signal generated by unwanted cross-hybridization, due to
the probes’ insuﬃcient speciﬁcity, is inevitable.
Finally, we have found transcripts targeted by many
(more than 10) probes, namely the major isoforms of
HYDIN (Supplementary Figure S16) and FAM90A1
(Supplementary Figure S17). Illumina probes were
designed so that the majority of genes would be targeted
by only one probe each (Supplementary Figure S6).
Therefore, contrary to Aﬀymetrix, no probe-level models
have been developed to summarize ‘probeset’ information.
In particular, the lack of a model taking into account the
relative matching position along the transcript might
reduce the precision of the gene expression measurements.
DISCUSSION
Designing the Illumina 50-mer probes might be considered
harder than the Aﬀymetrix 25-mers. Although designing
shorter probes is conditioned by a higher chance of
random matches to non-target sequences, it is known
that speciﬁcity of long probes decreases with growing
probe length, due to a higher probability of a probe
fragment matching an unwanted target (or even to fold,
self-hybridize and form a ‘hairpin’), thereby neutralizing
the gain in sensitivity associated with higher binding
energies (62). This is supported by our observation of gen-
erally high expression ranks of probes with mismatches
(‘Good’). Avoiding SNPs, which is more diﬃcult with
longer probes, is, therefore, important. Moreover, as the
GeneChip technology has been well established for over a
decade, there is more literature on thermal and hybridiza-
tion dynamics for Aﬀymetrix probes (63). It has been
shown that the base composition of 25-mers can aﬀect
the observed intensity and summarization methods have
been developed to deal with such eﬀects (64). To our
knowledge, only one study has investigated such eﬀects
for BeadArrays (5).
Nonetheless, BeadArrays have become increasingly
popular, not only because of their reliable measures of
what is targeted by the highly sensitive beads but also
due to their low bias and high precision. Our work
suggests that future studies should not overlook the
importance of annotating probe sequences and checking
if they target the desired features. Two previous
re-annotation eﬀorts (23,25) have mapped Illumina
probes to transcripts with reasonable success (despite
failing to recognize the strand speciﬁcity) but they are
not as extensive in investigating other factors that we
have shown to be important.
Our re-annotation depends on the accuracy of not only
the probe sequences provided by Illumina but also the
transcriptomic information in the public databases. The
impact of database content on microarray performance
and reproducibility has previously been shown (28).
For example, UCSC annotates the genomic locus of
GenBank mRNA AK024373 as spanning more than
2Mb of human chromosome 19 and many genes. Any
intergenic probe in that region (e.g. ILMN_1719185) will
be spuriously classiﬁed as intronic as a result of this.
Some ‘poorly designed’ probes can, on occasion, be
useful. Some intergenic probes may actually target novel
non-coding RNAs and intronic probes that can be used in
the detection of alternative splicing events involving the
retention of introns. Others can be seen as negative
controls. Their utility demands accurate annotation, as
the probes are not targeting the features they were
supposed to. Most ﬁltering approaches would likely
exclude these probes from the gene expression analysis,
otherwise it would be questionable whether they could
still be considered reliable or informative. There are
more suitable technologies for such applications anyway
(e.g. Aﬀymetrix Exon ST Arrays for the analysis of alter-
native splicing).
Preliminary ﬁltering to remove uninformative probes is
regarded as an essential part of the analysis and has been
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expression assessment (65). However, such ﬁltering is typ-
ically performed using measures based on expression level,
variability and ad hoc cut-oﬀs that can vary between
experiments. Such approaches also bias the downstream
analysis against transcripts that are relatively lowly
expressed and may still be biologically relevant. On the
other hand, probes with high signal caused by spurious
cross-hybridization would still be included. A clear
message from our investigations is that uninformative
probes may be identiﬁed by their re-annotation, and that
ﬁltering based on the quality of design and annotation
is an unbiased way of improving the speciﬁcity of an
analysis. It is worth bearing in mind that a probe perfectly
and uniquely matching its target may still be unreliable
due to its particular composition and hybridization
dynamics (5).
With the exception of Aﬀymetrix (57,66), very little is
reported about the impact of SNPs on the analysis of
expression data. The increase in the number of probe
pairs diﬀering in one nucleotide from older to recent
versions of BeadArray platforms suggests that the aspect
is now being given attention by Illumina. Even when we
can match up SNP/expression pairs, there may be no
expression registered (either due to probe design issues
or naturally), or no variation seen at the SNP within
this population. Furthermore, the location of the SNP
within the probe sequence will undoubtedly inﬂuence its
impact, as it has been reported for several SNP association
and expression quantitative trait loci studies (57, 67–69).
Many recent high impact studies have used BeadArrays
for gene expression analysis. The majority of Illumina
probes are of good quality and ﬁltering has enriched
analyses for these good quality probes. Therefore, most
of the biological inferences from those analyses should
be reliable. However, our work shows the possibility
for misinterpretation of results, as a consequence of
analyzing probes that should have been removed due to
poor design. For example, one of the key ﬁndings in (70)
is that the pluripotent cells share a protein–protein
network (PluriNet) that has a 299-gene signature. Our
re-annotation reveals that  8% of the associated 370
probes (Supplementary Table S3) can be considered
unreliable (‘Bad’) for targeting repeats, intronic regions
or annotated transcripts that cannot be aligned to the
genome. Furthermore, 80 of the reliable probes target
known SNPs. This has clear implications on the interpre-
tation of this signature.
Finally, eﬀorts like the present study should help the
microarray manufacturers to improve the probe design
of their new platforms. Nonetheless, it is important to
keep up-to-date annotation of probes for the existing
ones, as it provides the opportunity for improved
analysis of old data sets and can be an important tool
in large studies involving meta-analyses of data sets
generated from diﬀerent platforms. For instance, 6976
human and 31307 mouse probes have identical sequences
across all WG-6 version numbers (Supplementary
Figure S18), and, thus, have the potential to be
combined reliably in a meta-analysis. Using nuID (23)
or even the sequence itself as an universal probe identiﬁer
can aid in the creation of a single library of probes for
each species. Transcriptomic annotation would, therefore,
be particularly important in the meta-analysis of probes
from diﬀerent versions with the same target.
The Web interface and the periodic update of
Bioconductor packages will allow us to provide
updated re-annotation of the covered platforms, as the
genomic and transcriptomic databases also get updated.
Moreover, the described computational pipeline can be
used to re-annotate probes for virtually any microarray
application.
In summary, using the accurate, comprehensive and up-
to-date re-annotation of probes described herein improves
the accuracy of the analysis of Illumina microarray data
(including the re-analysis of previous studies) and widens
the scope of biological information that can be extracted
from BeadArray experiments.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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